BioHealth News
Maryland Industrial Partnerships (MIPS) – Proposals are due May 1!
Proposals are due May 1! Grants for Technology Product Development Market-driven new technology and innovation leads to new products and new jobs. Creating jobs…
Read MoreGermantown’s Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of Cancer Treatment – The MoCo Show
Deka Biosciences (“Deka”), a clinical-stage biotechnology company headquartered at 20271 Goldenrod Lane in Germantown and focused on developing novel cytokine therapies to treat cancer…
Read MoreTRUiC: 19 Best Angel Investor Groups for Startups
Angel investors are a great way to obtain startup funding for your business. Typically, angel investors for startups fund early and seed-stage companies that show promise for…
Read MoreMontgomery County Economic Development Corporation Adds New Board Members
April 12, 2023 Joining Experienced Business Executives Across Industries, Education and Government to Enhance Economic Development in Montgomery County Rockville, MD — Under the…
Read MoreBioBuzz: Here Are Several BioHealth Capital Region Life Science Companies Hiring Right Now: Q2 2023
By Alex KeownApril 13, 2023 Companies within the BioHealth Capital Region hub are hiring for multiple positions in Maryland, Virginia and Washington, D.C. BioBuzz rounds…
Read MoreCharlotte’s Tanner Pharma Group and Rockville’s ExeGi Pharma Announce Partnership to Distribute High Potency Probiotic
Partnership Announced to Distribute High Potency Probiotic in Mexico to Support Patients with Gut Microbiome Imbalance Rockville, M.D., and Charlotte, N.C., April 12, 2023…
Read MoreAltimmune Completes Enrollment In Phase 2 Clinical Trial Of HepTcell™, An Immunotherapeutic For Chronic Hepatitis B
April 11, 2023 at 7:30 AM EDT GAITHERSBURG, Md., April 11, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company (the Company), today announced that…
Read MoreREGENXBIO Receives FDA Fast Track Designation for RGX-202, a Novel Gene Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy
RGX-202 is a potential one-time AAV Therapeutic for the treatment of Duchenne and includes an optimized transgene for a novel microdystrophin and REGENXBIO's proprietary…
Read MoreWhite House amps up COVID vaccine development with Project NextGen
The Biden administration has announced a $5 billion program to accelerate the development of next-generation COVID-19 vaccines and treatments. Like Operation Warp Speed, which developed and…
Read MoreBHI Entrepreneur-in-Residence with NIH/NHLBI, Renée Arnold, Leads Trailblazing Discussion on Digital Health Innovation and Regulation for Dementia Caregiver Apps at ISPOR 2023 Conference
BioHealth Innovation's Renée Arnold is set to lead an insightful panel discussion at the upcoming ISPOR 2023 conference, which will take place on May…
Read MoreBizJournals – Baltimore digital health startup Scene Health raises $17.7 million in funding
A Baltimore startup that helps get patients to take their medications has raised one of the largest funding rounds in Baltimore so far this…
Read MoreThe BioTalk Podcast Welcomes Dr. Leroy Hood and Dr. Nathan Price, Co-Authors of “The Age of Scientific Wellness”
What if the future of medicine could be personalized, predictive, and empowered by data? In this episode of BioTalk, Rich Bendis discusses this topic…
Read MoreSBIR and STTR Applicants: Notice of Upcoming Changes Around Disclosures of Foreign Investments and Affiliations or Relationships | Fenwick & West LLP – JDSupra
TL/DR: For participation in the SBIR and STTR programs, agencies now have a standard set of questions to ask small business concerns about their foreign…
Read MoreNational Cancer Institute WebEx Enterprise Site – Register Meeting
Register to attend a free NIH webinar. Attendees will learn about a new method for administering Transcranial Magnetic Stimulation (TMS). This new method improves…
Read MoreUSP/BioPhorum Joint Workshop on Continuous Manufacturing of Biologics
Continuous manufacturing (CM) is an exciting frontier in drug manufacturing with the capacity to increase process efficiency while reducing costs. Manufacturers are now looking…
Read More